These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4816)

  • 1. Effect of various 6-hydroxydopamine treatments during development on growth and ingestive behavior.
    Breese GR; Smith RD; Cooper BR
    Pharmacol Biochem Behav; 1975; 3(6):1097-106. PubMed ID: 4816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery of feeding and drinking by rats after intraventricular 6-hydroxydopamine or lateral hypothalamic lesions.
    Zigmond MJ; Stricker EM
    Science; 1973 Nov; 182(4113):717-20. PubMed ID: 4752211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in consummatory behavior following intracisternal injection of 6-hydroxydopamine.
    Breese GR; Smith RD; Cooper BR; Grant LD
    Pharmacol Biochem Behav; 1973; 1(3):319-28. PubMed ID: 4775860
    [No Abstract]   [Full Text] [Related]  

  • 4. Growth and behavioral changes in developing rats treated intracisternally with 6-hydroxydopamine: evidence for involvement of brain dopamine.
    Smith RD; Cooper BR; Breese GR
    J Pharmacol Exp Ther; 1973 Jun; 185(3):609-19. PubMed ID: 4145870
    [No Abstract]   [Full Text] [Related]  

  • 5. Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: effects of 6-hydroxydopamine.
    Breese GR; Traylor TD
    Br J Pharmacol; 1972 Feb; 44(2):210-22. PubMed ID: 4148915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological and behavioral effects of centrally-administered 6-hydroxydopamine in cats.
    Howard JL; Breese GR
    Pharmacol Biochem Behav; 1974; 2(5):651-61. PubMed ID: 4431828
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of central catecholamine alterations by 6-hydroxydopamine on shuttle box avoidance acquistion.
    Cooper BR; Breese GR; Howard JL; Grant LD
    Physiol Behav; 1972; 9(5):727-31. PubMed ID: 4655165
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of intraventricular injections of 6-hydroxydopamine in neonatal rats on the catecholamine levels and tyrosine hydroxylase activity in brain regions at maturity.
    Peters DA; Pappas BA; Taub H; Saari M
    Biochem Pharmacol; 1977 Dec; 26(23):2211-5. PubMed ID: 22332
    [No Abstract]   [Full Text] [Related]  

  • 9. Feeding and drinking deficits after 6-hydroxydopamine administration in the rat: similarities to the lateral hypothalamic syndrome.
    Fibiger HC; Zis AP; McGeer EG
    Brain Res; 1973 May; 55(1):135-48. PubMed ID: 4145913
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of intra-amygdaloid injections of 6-hydroxy-dopamine on avoidance responding in rats.
    Ashford J; Jones BJ
    Br J Pharmacol; 1976 Mar; 56(3):255-61. PubMed ID: 1260169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intracisternal 6-hydroxydopamine treatment on acquisition and performance of rats in a double T-maze.
    Howard JL; Grant LD; Breese GR
    J Comp Physiol Psychol; 1974 Jun; 86(6):995-1007. PubMed ID: 4836849
    [No Abstract]   [Full Text] [Related]  

  • 12. Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine.
    Breese GR; Traylor TD
    Br J Pharmacol; 1971 May; 42(1):88-99. PubMed ID: 5580702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of avoidance deficits produced by 6-hydroxydopamine lesions of the nigrostriatal system of the rat.
    Delacour J; Echavarria MT; Senault B; Houcine O
    J Comp Physiol Psychol; 1977 Aug; 91(4):875-85. PubMed ID: 893749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of avoidance and ingestive behavior after destruction of central catecholamine pathways with 6-hydroxydopamine.
    Cooper BR; Howard JL; Grant LD; Smith RD; Breese GR
    Pharmacol Biochem Behav; 1974; 2(5):639-49. PubMed ID: 4610593
    [No Abstract]   [Full Text] [Related]  

  • 15. Consummatory behaviors of hypothalamic hyperphagic rats after central injection of 6-hydroxydopamine.
    Coscina DV; Rosenblum-Blinick C; Godse DD; Stancer HC
    Pharmacol Biochem Behav; 1973; 1(6):629-42. PubMed ID: 4785805
    [No Abstract]   [Full Text] [Related]  

  • 16. 6-Hydroxydopamine induced catecholamine depletion and passive avoidance learning in rats.
    Oei TP; Ng CP
    Pharmacol Biochem Behav; 1978 May; 8(5):553-6. PubMed ID: 674261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects on homeostasis of intraventricular injections of 6-hydroxydopamine in rats.
    Stricker EM; Zigmond MJ
    J Comp Physiol Psychol; 1974 Jun; 86(6):973-94. PubMed ID: 4836848
    [No Abstract]   [Full Text] [Related]  

  • 18. Learning impairment in rats after 6-hydroxydopamine-induced depletion of brain catecholamines.
    Mason ST; Iverson SD
    Nature; 1974 Apr; 248(5450):697-8. PubMed ID: 4151498
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular changes following DOCA-NaCl or conditioning in 6-hydroxydopamine-treated rats.
    Howard JL; Smith RD; Mueller RA; Breese GR
    Pharmacol Biochem Behav; 1974; 2(4):537-43. PubMed ID: 4153826
    [No Abstract]   [Full Text] [Related]  

  • 20. Deficits in instrumental responding after 6-hydroxydopamine lesions of the nigro-neostriatal dopaminergic projection.
    Fibiger HC; Phillips AG; Zis AP
    Pharmacol Biochem Behav; 1974; 2(1):87-96. PubMed ID: 4151316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.